Nu-Med Plus (NUMD, $0.02) was a top loser over the last three months, falling -6 to $0.02 per share. A.I.dvisor analyzed 422 stocks in the Medical Specialties Industry for the 3-month period ending November 11, 2024, and found that of them (5) exhibited an Uptrend while of them (4) demonstrated a Downtrend.